federal_register: 01-23325
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01-23325 | Medicare Program; Meeting of the Executive Committee of the Medicare Coverage Advisory Committee-October 17, 2001 | Notice | This notice announces a public meeting of the Executive Committee of the Medicare Coverage Advisory Committee (the Committee). The Committee will act on the recommendation of the Diagnostic Imaging panel regarding FDG Positron Emission Tomography (PET) imaging for breast cancer diagnosis and staging, and the recommendation of the Drugs, Biologics and Therapeutics panel regarding use of levocarntine in End Stage Renal Disease (ESRD) patients. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). | 2001-09-19 | 2001 | 9 | https://www.federalregister.gov/documents/2001/09/19/01-23325/medicare-program-meeting-of-the-executive-committee-of-the-medicare-coverage-advisory | https://www.govinfo.gov/content/pkg/FR-2001-09-19/pdf/01-23325.pdf | Health and Human Services Department; Centers for Medicare & Medicaid Services | 221,45 | This notice announces a public meeting of the Executive Committee of the Medicare Coverage Advisory Committee (the Committee). The Committee will act on the recommendation of the Diagnostic Imaging panel regarding FDG Positron Emission Tomography (PET)... |